nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—Benign breast neoplasm—Memantine—Alzheimer's disease	0.0716	0.144	CcSEcCtD
Spironolactone—Breast cancer—Rivastigmine—Alzheimer's disease	0.0201	0.0405	CcSEcCtD
Spironolactone—Rash erythematous—Memantine—Alzheimer's disease	0.00981	0.0197	CcSEcCtD
Spironolactone—Cramps of lower extremities—Galantamine—Alzheimer's disease	0.0098	0.0197	CcSEcCtD
Spironolactone—Rash erythematous—Rivastigmine—Alzheimer's disease	0.00959	0.0193	CcSEcCtD
Spironolactone—Breast pain—Rivastigmine—Alzheimer's disease	0.00842	0.0169	CcSEcCtD
Spironolactone—Lethargy—Galantamine—Alzheimer's disease	0.00791	0.0159	CcSEcCtD
Spironolactone—PGR—blood vessel—Alzheimer's disease	0.00773	0.0889	CbGeAlD
Spironolactone—Cramps of lower extremities—Donepezil—Alzheimer's disease	0.0076	0.0153	CcSEcCtD
Spironolactone—Vasculitis—Rivastigmine—Alzheimer's disease	0.00753	0.0151	CcSEcCtD
Spironolactone—Hyperkalaemia—Memantine—Alzheimer's disease	0.00738	0.0148	CcSEcCtD
Spironolactone—Ataxia—Galantamine—Alzheimer's disease	0.00728	0.0146	CcSEcCtD
Spironolactone—Gastritis—Galantamine—Alzheimer's disease	0.00686	0.0138	CcSEcCtD
Spironolactone—Cramps of lower extremities—Rivastigmine—Alzheimer's disease	0.00675	0.0136	CcSEcCtD
Spironolactone—Renal failure acute—Memantine—Alzheimer's disease	0.0059	0.0119	CcSEcCtD
Spironolactone—Renal failure—Galantamine—Alzheimer's disease	0.00587	0.0118	CcSEcCtD
Spironolactone—Renal failure acute—Rivastigmine—Alzheimer's disease	0.00578	0.0116	CcSEcCtD
Spironolactone—Ataxia—Donepezil—Alzheimer's disease	0.00565	0.0113	CcSEcCtD
Spironolactone—Lethargy—Memantine—Alzheimer's disease	0.00556	0.0112	CcSEcCtD
Spironolactone—Cramp muscle—Donepezil—Alzheimer's disease	0.00541	0.0109	CcSEcCtD
Spironolactone—Gastritis—Donepezil—Alzheimer's disease	0.00531	0.0107	CcSEcCtD
Spironolactone—Eosinophilia—Donepezil—Alzheimer's disease	0.00514	0.0103	CcSEcCtD
Spironolactone—Ataxia—Memantine—Alzheimer's disease	0.00513	0.0103	CcSEcCtD
Spironolactone—Ataxia—Rivastigmine—Alzheimer's disease	0.00501	0.0101	CcSEcCtD
Spironolactone—Gastritis—Memantine—Alzheimer's disease	0.00482	0.0097	CcSEcCtD
Spironolactone—Cramp muscle—Rivastigmine—Alzheimer's disease	0.0048	0.00965	CcSEcCtD
Spironolactone—Gastritis—Rivastigmine—Alzheimer's disease	0.00472	0.00948	CcSEcCtD
Spironolactone—Renal failure—Donepezil—Alzheimer's disease	0.00455	0.00914	CcSEcCtD
Spironolactone—Muscle spasms—Galantamine—Alzheimer's disease	0.00449	0.00901	CcSEcCtD
Spironolactone—NR3C2—forebrain—Alzheimer's disease	0.00439	0.0504	CbGeAlD
Spironolactone—Erectile dysfunction—Memantine—Alzheimer's disease	0.00434	0.00872	CcSEcCtD
Spironolactone—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00433	0.0087	CcSEcCtD
Spironolactone—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00425	0.00853	CcSEcCtD
Spironolactone—Malaise—Galantamine—Alzheimer's disease	0.00421	0.00845	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00417	0.00837	CcSEcCtD
Spironolactone—Renal failure—Memantine—Alzheimer's disease	0.00413	0.0083	CcSEcCtD
Spironolactone—Drowsiness—Rivastigmine—Alzheimer's disease	0.00411	0.00826	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00407	0.00819	CcSEcCtD
Spironolactone—Renal failure—Rivastigmine—Alzheimer's disease	0.00404	0.00812	CcSEcCtD
Spironolactone—NR3C2—telencephalon—Alzheimer's disease	0.00403	0.0464	CbGeAlD
Spironolactone—Discomfort—Galantamine—Alzheimer's disease	0.00392	0.00789	CcSEcCtD
Spironolactone—Agranulocytosis—Memantine—Alzheimer's disease	0.00392	0.00788	CcSEcCtD
Spironolactone—Confusional state—Galantamine—Alzheimer's disease	0.00384	0.00772	CcSEcCtD
Spironolactone—SLCO1A2—forebrain—Alzheimer's disease	0.00376	0.0432	CbGeAlD
Spironolactone—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00373	0.00749	CcSEcCtD
Spironolactone—Alopecia—Donepezil—Alzheimer's disease	0.00367	0.00738	CcSEcCtD
Spironolactone—Erythema multiforme—Memantine—Alzheimer's disease	0.00357	0.00717	CcSEcCtD
Spironolactone—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00349	0.00701	CcSEcCtD
Spironolactone—Muscle spasms—Donepezil—Alzheimer's disease	0.00348	0.00699	CcSEcCtD
Spironolactone—SLCO1A2—telencephalon—Alzheimer's disease	0.00346	0.0397	CbGeAlD
Spironolactone—Somnolence—Galantamine—Alzheimer's disease	0.00339	0.0068	CcSEcCtD
Spironolactone—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00335	0.00674	CcSEcCtD
Spironolactone—Alopecia—Memantine—Alzheimer's disease	0.00333	0.0067	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00329	0.00661	CcSEcCtD
Spironolactone—Malaise—Donepezil—Alzheimer's disease	0.00326	0.00655	CcSEcCtD
Spironolactone—Alopecia—Rivastigmine—Alzheimer's disease	0.00326	0.00655	CcSEcCtD
Spironolactone—AR—forebrain—Alzheimer's disease	0.00325	0.0373	CbGeAlD
Spironolactone—Feeling abnormal—Galantamine—Alzheimer's disease	0.00314	0.00631	CcSEcCtD
Spironolactone—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00309	0.00621	CcSEcCtD
Spironolactone—Ill-defined disorder—Memantine—Alzheimer's disease	0.00305	0.00612	CcSEcCtD
Spironolactone—Discomfort—Donepezil—Alzheimer's disease	0.00304	0.00611	CcSEcCtD
Spironolactone—Body temperature increased—Galantamine—Alzheimer's disease	0.00301	0.00605	CcSEcCtD
Spironolactone—AR—telencephalon—Alzheimer's disease	0.00299	0.0343	CbGeAlD
Spironolactone—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00298	0.00599	CcSEcCtD
Spironolactone—Confusional state—Donepezil—Alzheimer's disease	0.00298	0.00598	CcSEcCtD
Spironolactone—Malaise—Memantine—Alzheimer's disease	0.00296	0.00595	CcSEcCtD
Spironolactone—Leukopenia—Memantine—Alzheimer's disease	0.00294	0.00591	CcSEcCtD
Spironolactone—Malaise—Rivastigmine—Alzheimer's disease	0.0029	0.00582	CcSEcCtD
Spironolactone—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00289	0.00581	CcSEcCtD
Spironolactone—Hypersensitivity—Galantamine—Alzheimer's disease	0.00281	0.00564	CcSEcCtD
Spironolactone—Discomfort—Memantine—Alzheimer's disease	0.00276	0.00555	CcSEcCtD
Spironolactone—Confusional state—Memantine—Alzheimer's disease	0.0027	0.00543	CcSEcCtD
Spironolactone—Discomfort—Rivastigmine—Alzheimer's disease	0.0027	0.00543	CcSEcCtD
Spironolactone—NR3C1—embryo—Alzheimer's disease	0.00266	0.0306	CbGeAlD
Spironolactone—Confusional state—Rivastigmine—Alzheimer's disease	0.00264	0.00531	CcSEcCtD
Spironolactone—Somnolence—Donepezil—Alzheimer's disease	0.00262	0.00527	CcSEcCtD
Spironolactone—Thrombocytopenia—Memantine—Alzheimer's disease	0.00262	0.00527	CcSEcCtD
Spironolactone—Diarrhoea—Galantamine—Alzheimer's disease	0.00261	0.00524	CcSEcCtD
Spironolactone—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00257	0.00516	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00255	0.00512	CcSEcCtD
Spironolactone—Dizziness—Galantamine—Alzheimer's disease	0.00252	0.00506	CcSEcCtD
Spironolactone—Feeling abnormal—Donepezil—Alzheimer's disease	0.00243	0.00489	CcSEcCtD
Spironolactone—Vomiting—Galantamine—Alzheimer's disease	0.00242	0.00487	CcSEcCtD
Spironolactone—Rash—Galantamine—Alzheimer's disease	0.0024	0.00482	CcSEcCtD
Spironolactone—Dermatitis—Galantamine—Alzheimer's disease	0.0024	0.00482	CcSEcCtD
Spironolactone—ABCB1—blood vessel—Alzheimer's disease	0.00239	0.0274	CbGeAlD
Spironolactone—Headache—Galantamine—Alzheimer's disease	0.00239	0.00479	CcSEcCtD
Spironolactone—Somnolence—Memantine—Alzheimer's disease	0.00238	0.00479	CcSEcCtD
Spironolactone—NR3C2—nervous system—Alzheimer's disease	0.00238	0.0274	CbGeAlD
Spironolactone—SHBG—central nervous system—Alzheimer's disease	0.00237	0.0272	CbGeAlD
Spironolactone—NR3C1—forebrain—Alzheimer's disease	0.00235	0.027	CbGeAlD
Spironolactone—Urticaria—Donepezil—Alzheimer's disease	0.00234	0.00471	CcSEcCtD
Spironolactone—Body temperature increased—Donepezil—Alzheimer's disease	0.00233	0.00469	CcSEcCtD
Spironolactone—Somnolence—Rivastigmine—Alzheimer's disease	0.00233	0.00468	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00231	0.00465	CcSEcCtD
Spironolactone—SHBG—cerebellum—Alzheimer's disease	0.00231	0.0266	CbGeAlD
Spironolactone—NR3C2—central nervous system—Alzheimer's disease	0.00229	0.0264	CbGeAlD
Spironolactone—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00226	0.00455	CcSEcCtD
Spironolactone—Nausea—Galantamine—Alzheimer's disease	0.00226	0.00455	CcSEcCtD
Spironolactone—NR3C2—cerebellum—Alzheimer's disease	0.00224	0.0258	CbGeAlD
Spironolactone—PGR—nervous system—Alzheimer's disease	0.00221	0.0254	CbGeAlD
Spironolactone—Feeling abnormal—Memantine—Alzheimer's disease	0.00221	0.00444	CcSEcCtD
Spironolactone—Hypersensitivity—Donepezil—Alzheimer's disease	0.00217	0.00437	CcSEcCtD
Spironolactone—NR3C1—telencephalon—Alzheimer's disease	0.00216	0.0249	CbGeAlD
Spironolactone—Drospirenone—BCHE—Alzheimer's disease	0.00216	0.298	CrCbGaD
Spironolactone—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00216	0.00434	CcSEcCtD
Spironolactone—PGR—central nervous system—Alzheimer's disease	0.00213	0.0245	CbGeAlD
Spironolactone—Urticaria—Memantine—Alzheimer's disease	0.00213	0.00428	CcSEcCtD
Spironolactone—Body temperature increased—Memantine—Alzheimer's disease	0.00212	0.00426	CcSEcCtD
Spironolactone—Pruritus—Donepezil—Alzheimer's disease	0.00209	0.0042	CcSEcCtD
Spironolactone—PGR—cerebellum—Alzheimer's disease	0.00208	0.0239	CbGeAlD
Spironolactone—Urticaria—Rivastigmine—Alzheimer's disease	0.00208	0.00418	CcSEcCtD
Spironolactone—Body temperature increased—Rivastigmine—Alzheimer's disease	0.00207	0.00416	CcSEcCtD
Spironolactone—SLCO1A2—nervous system—Alzheimer's disease	0.00204	0.0235	CbGeAlD
Spironolactone—Diarrhoea—Donepezil—Alzheimer's disease	0.00202	0.00406	CcSEcCtD
Spironolactone—Hypersensitivity—Memantine—Alzheimer's disease	0.00197	0.00397	CcSEcCtD
Spironolactone—SLCO1A2—central nervous system—Alzheimer's disease	0.00197	0.0226	CbGeAlD
Spironolactone—Dizziness—Donepezil—Alzheimer's disease	0.00195	0.00392	CcSEcCtD
Spironolactone—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00193	0.00388	CcSEcCtD
Spironolactone—SLCO1A2—cerebellum—Alzheimer's disease	0.00192	0.0221	CbGeAlD
Spironolactone—Pruritus—Memantine—Alzheimer's disease	0.0019	0.00381	CcSEcCtD
Spironolactone—SHBG—brain—Alzheimer's disease	0.00188	0.0216	CbGeAlD
Spironolactone—Vomiting—Donepezil—Alzheimer's disease	0.00188	0.00377	CcSEcCtD
Spironolactone—Rash—Donepezil—Alzheimer's disease	0.00186	0.00374	CcSEcCtD
Spironolactone—Dermatitis—Donepezil—Alzheimer's disease	0.00186	0.00374	CcSEcCtD
Spironolactone—Pruritus—Rivastigmine—Alzheimer's disease	0.00185	0.00373	CcSEcCtD
Spironolactone—Headache—Donepezil—Alzheimer's disease	0.00185	0.00371	CcSEcCtD
Spironolactone—Diarrhoea—Memantine—Alzheimer's disease	0.00183	0.00368	CcSEcCtD
Spironolactone—NR3C2—brain—Alzheimer's disease	0.00182	0.0209	CbGeAlD
Spironolactone—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00179	0.0036	CcSEcCtD
Spironolactone—Dizziness—Memantine—Alzheimer's disease	0.00177	0.00356	CcSEcCtD
Spironolactone—AR—nervous system—Alzheimer's disease	0.00176	0.0203	CbGeAlD
Spironolactone—Nausea—Donepezil—Alzheimer's disease	0.00175	0.00352	CcSEcCtD
Spironolactone—Dizziness—Rivastigmine—Alzheimer's disease	0.00173	0.00348	CcSEcCtD
Spironolactone—Vomiting—Memantine—Alzheimer's disease	0.0017	0.00342	CcSEcCtD
Spironolactone—AR—central nervous system—Alzheimer's disease	0.0017	0.0195	CbGeAlD
Spironolactone—PGR—brain—Alzheimer's disease	0.00169	0.0195	CbGeAlD
Spironolactone—Rash—Memantine—Alzheimer's disease	0.00169	0.00339	CcSEcCtD
Spironolactone—Dermatitis—Memantine—Alzheimer's disease	0.00169	0.00339	CcSEcCtD
Spironolactone—Headache—Memantine—Alzheimer's disease	0.00168	0.00337	CcSEcCtD
Spironolactone—Vomiting—Rivastigmine—Alzheimer's disease	0.00167	0.00335	CcSEcCtD
Spironolactone—Rash—Rivastigmine—Alzheimer's disease	0.00165	0.00332	CcSEcCtD
Spironolactone—Dermatitis—Rivastigmine—Alzheimer's disease	0.00165	0.00332	CcSEcCtD
Spironolactone—Headache—Rivastigmine—Alzheimer's disease	0.00164	0.0033	CcSEcCtD
Spironolactone—Nausea—Memantine—Alzheimer's disease	0.00159	0.0032	CcSEcCtD
Spironolactone—SLCO1A2—brain—Alzheimer's disease	0.00156	0.0179	CbGeAlD
Spironolactone—Nausea—Rivastigmine—Alzheimer's disease	0.00156	0.00313	CcSEcCtD
Spironolactone—Fluoxymesterone—ESR1—Alzheimer's disease	0.00155	0.213	CrCbGaD
Spironolactone—ABCB1—embryo—Alzheimer's disease	0.00142	0.0164	CbGeAlD
Spironolactone—AR—brain—Alzheimer's disease	0.00135	0.0155	CbGeAlD
Spironolactone—Medroxyprogesterone Acetate—ESR1—Alzheimer's disease	0.00133	0.183	CrCbGaD
Spironolactone—NR3C1—nervous system—Alzheimer's disease	0.00128	0.0147	CbGeAlD
Spironolactone—ABCB1—forebrain—Alzheimer's disease	0.00126	0.0145	CbGeAlD
Spironolactone—NR3C1—central nervous system—Alzheimer's disease	0.00123	0.0141	CbGeAlD
Spironolactone—NR3C1—cerebellum—Alzheimer's disease	0.0012	0.0138	CbGeAlD
Spironolactone—ABCB1—telencephalon—Alzheimer's disease	0.00116	0.0133	CbGeAlD
Spironolactone—CYP2C8—brain—Alzheimer's disease	0.00109	0.0125	CbGeAlD
Spironolactone—Drospirenone—PTGS2—Alzheimer's disease	0.000996	0.137	CrCbGaD
Spironolactone—NR3C1—brain—Alzheimer's disease	0.000976	0.0112	CbGeAlD
Spironolactone—Progesterone—ESR1—Alzheimer's disease	0.000768	0.106	CrCbGaD
Spironolactone—ABCB1—nervous system—Alzheimer's disease	0.000684	0.00786	CbGeAlD
Spironolactone—ABCB1—central nervous system—Alzheimer's disease	0.000658	0.00757	CbGeAlD
Spironolactone—ABCB1—cerebellum—Alzheimer's disease	0.000643	0.0074	CbGeAlD
Spironolactone—ABCB1—brain—Alzheimer's disease	0.000523	0.00601	CbGeAlD
Spironolactone—Progesterone—CYP2D6—Alzheimer's disease	0.000457	0.0629	CrCbGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	0.000152	0.000372	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PLCB1—Alzheimer's disease	0.000152	0.000372	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—Alzheimer's disease	0.000152	0.000372	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TGFB1—Alzheimer's disease	0.000151	0.00037	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GFAP—Alzheimer's disease	0.00015	0.000367	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GAL—Alzheimer's disease	0.00015	0.000367	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS1—Alzheimer's disease	0.000149	0.000365	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ENO1—Alzheimer's disease	0.000149	0.000365	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000149	0.000365	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ABCA1—Alzheimer's disease	0.000147	0.00036	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	0.000146	0.000358	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CYP2D6—Alzheimer's disease	0.000146	0.000358	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000146	0.000357	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	0.000145	0.000356	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—ESR1—Alzheimer's disease	0.000145	0.000356	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000142	0.000349	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000142	0.000348	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000142	0.000348	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—TNF—Alzheimer's disease	0.000141	0.000345	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—NOTCH1—Alzheimer's disease	0.00014	0.000344	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.00014	0.000343	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.00014	0.000343	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—BCHE—Alzheimer's disease	0.000139	0.000339	CbGpPWpGaD
Spironolactone—AR—Gene Expression—EIF2S1—Alzheimer's disease	0.000138	0.000338	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	0.000137	0.000335	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000135	0.000332	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—DHCR24—Alzheimer's disease	0.000133	0.000325	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000133	0.000325	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PPARG—Alzheimer's disease	0.000133	0.000325	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—A2M—Alzheimer's disease	0.000132	0.000324	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	0.000132	0.000322	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PLCB1—Alzheimer's disease	0.000131	0.00032	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.00013	0.000317	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CA4—Alzheimer's disease	0.000129	0.000317	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TPI1—Alzheimer's disease	0.000129	0.000315	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CHAT—Alzheimer's disease	0.000129	0.000315	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000128	0.000314	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PSEN2—Alzheimer's disease	0.000128	0.000314	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.000128	0.000313	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PPARGC1A—Alzheimer's disease	0.000127	0.000311	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ABCA1—Alzheimer's disease	0.000127	0.00031	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000126	0.00031	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—HMOX1—Alzheimer's disease	0.000126	0.000309	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MAOB—Alzheimer's disease	0.000123	0.000302	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	0.000123	0.000301	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000122	0.000298	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GAPDHS—Alzheimer's disease	0.000122	0.000298	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	0.000121	0.000296	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	0.00012	0.000295	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GAPDH—Alzheimer's disease	0.000119	0.000291	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NPY—Alzheimer's disease	0.000118	0.000289	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000117	0.000288	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IAPP—Alzheimer's disease	0.000117	0.000287	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000116	0.000285	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—LPL—Alzheimer's disease	0.000115	0.000283	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ATP5A1—Alzheimer's disease	0.000115	0.000283	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.000115	0.000281	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—A2M—Alzheimer's disease	0.000115	0.000281	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—IL6—Alzheimer's disease	0.000114	0.000279	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CRH—Alzheimer's disease	0.000114	0.000278	CbGpPWpGaD
Spironolactone—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	0.000113	0.000276	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CA4—Alzheimer's disease	0.000113	0.000276	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLD3—Alzheimer's disease	0.00011	0.00027	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.00011	0.00027	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPARGC1A—Alzheimer's disease	0.000109	0.000268	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000109	0.000266	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—HMOX1—Alzheimer's disease	0.000109	0.000266	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NPS—Alzheimer's disease	0.000108	0.000264	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000107	0.000263	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.000106	0.00026	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	0.000106	0.00026	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTK2B—Alzheimer's disease	0.000106	0.000259	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HSD17B10—Alzheimer's disease	0.000105	0.000258	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000105	0.000257	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—EIF2S1—Alzheimer's disease	0.000105	0.000257	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—MTHFR—Alzheimer's disease	0.000104	0.000255	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.000103	0.000253	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000103	0.000253	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NTRK2—Alzheimer's disease	0.000103	0.000252	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GAB2—Alzheimer's disease	0.000103	0.000252	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SST—Alzheimer's disease	0.000103	0.000252	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000103	0.000252	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000102	0.00025	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GSK3A—Alzheimer's disease	0.000102	0.00025	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	0.000102	0.000249	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP46A1—Alzheimer's disease	0.000102	0.000249	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	0.0001	0.000246	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APP—Alzheimer's disease	0.0001	0.000245	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ACHE—Alzheimer's disease	9.97e-05	0.000244	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—LPL—Alzheimer's disease	9.94e-05	0.000244	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	9.94e-05	0.000244	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—INPP5D—Alzheimer's disease	9.86e-05	0.000242	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	9.83e-05	0.000241	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ND1—Alzheimer's disease	9.81e-05	0.00024	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CALM1—Alzheimer's disease	9.71e-05	0.000238	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	9.69e-05	0.000238	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—PPARG—Alzheimer's disease	9.69e-05	0.000237	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—APOE—Alzheimer's disease	9.67e-05	0.000237	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLD3—Alzheimer's disease	9.59e-05	0.000235	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	9.58e-05	0.000235	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—CAV1—Alzheimer's disease	9.58e-05	0.000235	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PLCB1—Alzheimer's disease	9.45e-05	0.000232	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS1—Alzheimer's disease	9.34e-05	0.000229	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ENO1—Alzheimer's disease	9.34e-05	0.000229	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	9.19e-05	0.000225	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP2D6—Alzheimer's disease	9.16e-05	0.000225	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—MTHFR—Alzheimer's disease	8.95e-05	0.000219	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	8.91e-05	0.000218	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	8.85e-05	0.000217	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—ESR1—Alzheimer's disease	8.85e-05	0.000217	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NGFR—Alzheimer's disease	8.82e-05	0.000216	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	8.77e-05	0.000215	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—BCHE—Alzheimer's disease	8.69e-05	0.000213	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	8.68e-05	0.000213	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ADAM10—Alzheimer's disease	8.61e-05	0.000211	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—NOTCH1—Alzheimer's disease	8.55e-05	0.00021	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ND1—Alzheimer's disease	8.54e-05	0.000209	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PPARG—Alzheimer's disease	8.42e-05	0.000206	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CALM1—Alzheimer's disease	8.36e-05	0.000205	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—APOE—Alzheimer's disease	8.33e-05	0.000204	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—INS—Alzheimer's disease	8.26e-05	0.000202	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CAV1—Alzheimer's disease	8.26e-05	0.000202	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	8.24e-05	0.000202	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PLCB1—Alzheimer's disease	8.2e-05	0.000201	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—S100B—Alzheimer's disease	8.14e-05	0.0002	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PPARG—Alzheimer's disease	8.07e-05	0.000198	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	8.04e-05	0.000197	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ABCA1—Alzheimer's disease	7.94e-05	0.000195	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF2—Alzheimer's disease	7.75e-05	0.00019	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	7.65e-05	0.000187	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	7.56e-05	0.000185	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1R—Alzheimer's disease	7.5e-05	0.000184	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPARG—Alzheimer's disease	7.26e-05	0.000178	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NOS3—Alzheimer's disease	7.25e-05	0.000178	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LPL—Alzheimer's disease	7.19e-05	0.000176	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MEF2C—Alzheimer's disease	7.12e-05	0.000175	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—INS—Alzheimer's disease	7.12e-05	0.000174	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	7.03e-05	0.000172	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PRKCG—Alzheimer's disease	6.99e-05	0.000171	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	6.88e-05	0.000169	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARGC1A—Alzheimer's disease	6.85e-05	0.000168	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HMOX1—Alzheimer's disease	6.82e-05	0.000167	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NGF—Alzheimer's disease	6.81e-05	0.000167	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ESR1—Alzheimer's disease	6.74e-05	0.000165	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—Alzheimer's disease	6.63e-05	0.000162	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCR5—Alzheimer's disease	6.62e-05	0.000162	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH1—Alzheimer's disease	6.51e-05	0.00016	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	6.49e-05	0.000159	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HTR2A—Alzheimer's disease	6.48e-05	0.000159	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CHAT—Alzheimer's disease	6.32e-05	0.000155	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TPI1—Alzheimer's disease	6.32e-05	0.000155	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NOS3—Alzheimer's disease	6.24e-05	0.000153	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—LPL—Alzheimer's disease	6.23e-05	0.000153	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	6.23e-05	0.000153	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARG—Alzheimer's disease	6.15e-05	0.000151	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MAOB—Alzheimer's disease	6.06e-05	0.000148	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CALM1—Alzheimer's disease	6.05e-05	0.000148	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LEP—Alzheimer's disease	6.02e-05	0.000148	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APOE—Alzheimer's disease	6.02e-05	0.000148	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CAV1—Alzheimer's disease	5.97e-05	0.000146	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	5.96e-05	0.000146	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	5.83e-05	0.000143	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.77e-05	0.000141	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ESR1—Alzheimer's disease	5.75e-05	0.000141	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.71e-05	0.00014	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—Alzheimer's disease	5.71e-05	0.00014	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—F2—Alzheimer's disease	5.68e-05	0.000139	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—A2M—Alzheimer's disease	5.63e-05	0.000138	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—Alzheimer's disease	5.61e-05	0.000138	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	5.56e-05	0.000136	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH1—Alzheimer's disease	5.56e-05	0.000136	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TPI1—Alzheimer's disease	5.51e-05	0.000135	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CHAT—Alzheimer's disease	5.51e-05	0.000135	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MAOB—Alzheimer's disease	5.28e-05	0.000129	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CALM1—Alzheimer's disease	5.24e-05	0.000129	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—Alzheimer's disease	5.24e-05	0.000128	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—APOE—Alzheimer's disease	5.23e-05	0.000128	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GSK3B—Alzheimer's disease	5.22e-05	0.000128	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CAV1—Alzheimer's disease	5.18e-05	0.000127	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CREB1—Alzheimer's disease	5.17e-05	0.000127	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—INS—Alzheimer's disease	5.15e-05	0.000126	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR1—Alzheimer's disease	5.11e-05	0.000125	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GAPDH—Alzheimer's disease	5.08e-05	0.000124	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCL2—Alzheimer's disease	5.06e-05	0.000124	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.02e-05	0.000123	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1—Alzheimer's disease	4.98e-05	0.000122	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	4.94e-05	0.000121	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—A2M—Alzheimer's disease	4.91e-05	0.00012	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	4.91e-05	0.00012	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ACHE—Alzheimer's disease	4.9e-05	0.00012	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	4.84e-05	0.000119	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARG—Alzheimer's disease	4.66e-05	0.000114	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO1—Alzheimer's disease	4.59e-05	0.000113	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	4.59e-05	0.000113	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARG—Alzheimer's disease	4.55e-05	0.000112	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOS3—Alzheimer's disease	4.51e-05	0.000111	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	4.5e-05	0.00011	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—INS—Alzheimer's disease	4.46e-05	0.000109	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ACHE—Alzheimer's disease	4.27e-05	0.000105	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—BCHE—Alzheimer's disease	4.27e-05	0.000105	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—INPP5D—Alzheimer's disease	4.22e-05	0.000103	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	4.14e-05	0.000102	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	4.03e-05	9.87e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS1—Alzheimer's disease	4e-05	9.8e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO1—Alzheimer's disease	4e-05	9.8e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.95e-05	9.68e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	3.92e-05	9.61e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NOS3—Alzheimer's disease	3.91e-05	9.59e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	3.9e-05	9.57e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP3—Alzheimer's disease	3.83e-05	9.39e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—BCHE—Alzheimer's disease	3.72e-05	9.11e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—Alzheimer's disease	3.58e-05	8.77e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK8—Alzheimer's disease	3.52e-05	8.63e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLCB1—Alzheimer's disease	3.51e-05	8.6e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCA1—Alzheimer's disease	3.4e-05	8.33e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	3.36e-05	8.24e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	3.35e-05	8.21e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—Alzheimer's disease	3.33e-05	8.16e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—Alzheimer's disease	3.25e-05	7.97e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—Alzheimer's disease	3.19e-05	7.82e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LPL—Alzheimer's disease	3.06e-05	7.51e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFB1—Alzheimer's disease	2.98e-05	7.31e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	2.93e-05	7.18e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HMOX1—Alzheimer's disease	2.92e-05	7.15e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—Alzheimer's disease	2.87e-05	7.03e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	2.76e-05	6.76e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LPL—Alzheimer's disease	2.67e-05	6.54e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CALM1—Alzheimer's disease	2.58e-05	6.31e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—APOE—Alzheimer's disease	2.57e-05	6.29e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CAV1—Alzheimer's disease	2.54e-05	6.23e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—Alzheimer's disease	2.46e-05	6.02e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—Alzheimer's disease	2.43e-05	5.96e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.4e-05	5.89e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—Alzheimer's disease	2.25e-05	5.51e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.24e-05	5.5e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—APOE—Alzheimer's disease	2.24e-05	5.48e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARG—Alzheimer's disease	2.24e-05	5.48e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.22e-05	5.43e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—INS—Alzheimer's disease	2.19e-05	5.38e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—Alzheimer's disease	2.07e-05	5.08e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.95e-05	4.77e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NOS3—Alzheimer's disease	1.92e-05	4.71e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—INS—Alzheimer's disease	1.91e-05	4.68e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—Alzheimer's disease	1.84e-05	4.52e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—Alzheimer's disease	1.8e-05	4.41e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	1.76e-05	4.31e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.68e-05	4.11e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.53e-05	3.76e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—Alzheimer's disease	8.84e-06	2.17e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—Alzheimer's disease	7.7e-06	1.89e-05	CbGpPWpGaD
